Sitagliptin/Metformin Pharmacare 50 mg/850 mg film-coated tablets Malta - English - Medicines Authority

sitagliptin/metformin pharmacare 50 mg/850 mg film-coated tablets

pharmacare srl via marghera, 29 20149, milan, italy - film-coated tablet - sitagliptin 50 mg metformin hydrochloride 850 mg - drugs used in diabetes

Sitagliptin/Metformin Pharmacare 50 mg/1000 mg film-coated tablets Malta - English - Medicines Authority

sitagliptin/metformin pharmacare 50 mg/1000 mg film-coated tablets

pharmacare srl via marghera, 29 20149, milan, italy - film-coated tablet - sitagliptin 50 mg metformin hydrochloride 1000 mg - drugs used in diabetes

Sitagliptin Pharmacare 25 mg film-coated tablets Malta - English - Medicines Authority

sitagliptin pharmacare 25 mg film-coated tablets

pharmacare srl via marghera, 29 20149, milan, italy - film-coated tablet - sitagliptin 25 mg - drugs used in diabetes

Sitagliptin Pharmacare 50 mg film-coated tablets Malta - English - Medicines Authority

sitagliptin pharmacare 50 mg film-coated tablets

pharmacare srl via marghera, 29 20149, milan, italy - film-coated tablet - sitagliptin 50 mg - drugs used in diabetes

Sitagliptin Pharmacare 100 mg film-coated tablets Malta - English - Medicines Authority

sitagliptin pharmacare 100 mg film-coated tablets

pharmacare srl via marghera, 29 20149, milan, italy - film-coated tablet - sitagliptin 100 mg - drugs used in diabetes

ORKAMBI 200/125 lumacaftor/ivacaftor 200mg/125mg film-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

orkambi 200/125 lumacaftor/ivacaftor 200mg/125mg film-coated tablet blister pack

vertex pharmaceuticals australia pty ltd - ivacaftor, quantity: 125 mg; lumacaftor, quantity: 200 mg - tablet, film coated - excipient ingredients: hypromellose acetate succinate; sodium lauryl sulfate; microcrystalline cellulose; povidone; magnesium stearate; croscarmellose sodium; titanium dioxide; purified water; purified talc; brilliant blue fcf aluminium lake; polyvinyl alcohol; macrogol 3350; cochineal; indigo carmine aluminium lake; propylene glycol; butan-1-ol; isopropyl alcohol; strong ammonia solution; iron oxide black; ethanol; shellac; sulfuric acid - orkambi is indicated for the treatment of cystic fibrosis (cf) in patients aged 1 year and older who are homozygous for the f508del mutation in the cftr gene.

Sunitinib Pharmacare 12.5 mg hard capsules Malta - English - Medicines Authority

sunitinib pharmacare 12.5 mg hard capsules

pharmacare premium limited hhf 003 halfar industrial estate birzebbugia bbg 3000, malta - hard capsule - sunitinib 12.5 mg - antineoplastic agents

Sunitinib Pharmacare 25 mg hard capsules Malta - English - Medicines Authority

sunitinib pharmacare 25 mg hard capsules

pharmacare premium limited hhf 003 halfar industrial estate birzebbugia bbg 3000, malta - hard capsule - sunitinib 25 mg - antineoplastic agents

Sunitinib Pharmacare 37.5 mg hard capsules Malta - English - Medicines Authority

sunitinib pharmacare 37.5 mg hard capsules

pharmacare premium limited hhf 003 halfar industrial estate birzebbugia bbg 3000, malta - hard capsule - sunitinib 37.5 mg - antineoplastic agents

Sunitinib Pharmacare 50 mg hard capsules Malta - English - Medicines Authority

sunitinib pharmacare 50 mg hard capsules

pharmacare premium limited hhf 003 halfar industrial estate birzebbugia bbg 3000, malta - hard capsule - sunitinib 50 mg - antineoplastic agents